Nano-X Imaging Ltd.

NNOX ·Healthcare, Medical Devices, Israel
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-75.0M $-53.5M $-60.8M $-113.2M $-61.8M $-43.8M $-22.6M $-1.9M
Depreciation & Amortization — — — — — $208.0K — —
Depreciation $1.2M $1.1M $1.2M $905.0K $524.0K $208.0K $53.0K $35.0K
Amortization $10.5M $10.6M $10.6M $10.6M $1.8M — — —
Stock-Based Compensation $4.2M $7.3M $6.8M $18.6M $18.8M $24.8M $16.2M $115.0K
Net Cash from Operating Activities $-40.8M $-36.6M $-44.8M $-43.4M $-38.1M $-21.6M $-5.5M $-3.7M
Investing Activities
Capital Expenditures $4.2M $2.8M $3.3M $7.2M $23.2M $13.9M $125.0K $73.0K
Business Acquisitions $200.0K — — — $2.9M — — —
Net Cash from Investing Activities $29.4M $-20.1M $35.4M $14.6M $-116.3M $-13.9M $-125.0K $-73.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $21.4M $39.5M $27.3M $804.0K $7.4M $241.0M $13.9M $3.7M
Net Change in Cash $9.8M $-17.1M $17.8M $-28.2M $-147.0M $205.6M $8.2M $-60.0K
Free Cash Flow $-45.0M $-39.4M $-48.1M $-50.6M $-61.2M $-35.5M $-5.6M $-3.7M